This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Avid Bioservices, Inc.
12/2/2020
Good day, ladies and gentlemen, and welcome to the AVID Bioservices Second Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, this conference call may be recorded. I would now like to hand the conference over to Tim Bronze of AVID Investor Relations Group. Please go ahead.
Thank you. Good afternoon, and thank you for joining us. On today's call, we have Nick Greene, President and CEO, Dan Hart, Chief Financial Officer, and Timothy Compton, Chief Commercial Officer. Today, we will be providing an overview of Abbott Bioservices' contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended October 31, 2020. After our prepared remarks, we will welcome your questions.
When it comes to ultra-low temperature freezers, your research demands consistent, dependable technology. Meet PHCBI Brand Products VIP Eco. Call your local representative or visit us on the web for more information.
You're reading a preview of the CDMO Q2 2021 earnings call.
Free account.